Ozempic side effects on TikTok: what the studies actually show

What did @acecreations343 actually say?

The creator shared their first week on what they called "Zampic" (almost certainly semaglutide, brand name Ozempic), explaining they were prescribed it after struggling to lose weight, receiving a high HbA1c result, and already being on metformin for type 2 diabetes. They filmed the contents of their first box, showing the pre-filled pen and the disposable needles, noting "you replace each time you use it." The video is framed as a personal journey log, not medical advice, and the creator is open about their diabetes diagnosis and prior medication history.

The tone is honest and relatable. There are no wild cure claims, no dramatic before-and-after promises. It is someone unboxing a prescription they were legitimately given, which is a reasonable thing to document. The medical context they provide, type 2 diabetes plus metformin plus elevated HbA1c, is actually clinically relevant to why semaglutide would be prescribed.

Does the science back this up?

The clinical picture they describe matches the evidence for semaglutide use reasonably well. Semaglutide is FDA-approved for type 2 diabetes management (as Ozempic) and for chronic weight management (as Wegovy), and adding it to metformin is a documented treatment strategy.

The SUSTAIN trial series (Marso et al., 2016, New England Journal of Medicine) demonstrated that semaglutide reduced HbA1c and body weight significantly in type 2 diabetic patients already on oral medications including metformin. The STEP trials (Wilding et al., 2021, New England Journal of Medicine) further confirmed meaningful weight reduction in people with and without diabetes. So the combination of high HbA1c, type 2 diabetes, and prior metformin use is a textbook indication for adding a GLP-1 receptor agonist. The creator did not overstate what the drug does. They simply said it was prescribed after other attempts failed, which aligns with stepped-care diabetes management guidelines from the American Diabetes Association (Standards of Care, 2024).

What did they get wrong (or right)?

The most obvious error is the drug name. They consistently say "Zampic," which is not a real medication. The drug is Ozempic (semaglutide, manufactured by Novo Nordisk). This is likely a pronunciation mishearing or early confusion with the brand name, and probably not intentional misinformation, but it matters because viewers searching for accurate information may not connect the two.

On the pen mechanics, they say the needles are replaced each time you use it. That is correct. Ozempic uses disposable, single-use pen needles that attach to the pre-filled pen, and the pen itself contains multiple doses. Reusing needles increases infection risk and can degrade the needle tip, causing more injection site pain. Getting this right is worth crediting because a lot of first-time users do not know to swap the needle every single injection.

They also correctly note the pen must be stored in the fridge, asking "can I stay in the fridge?" Novo Nordisk prescribing information confirms unopened Ozempic pens should be refrigerated at 36 to 46 degrees Fahrenheit, and in-use pens can be kept at room temperature for up to 56 days. No errors there.

What should you actually know?

If you have type 2 diabetes, a high HbA1c, and are already on metformin, semaglutide is a well-studied second-line or add-on option. It is not a cure and it does not work in isolation. Diet, activity, and ongoing medical monitoring still matter.

A few things this video does not cover that you should ask your prescriber about. First, nausea and gastrointestinal side effects are the most common reason people stop GLP-1 therapy, reported in 15 to 44 percent of patients depending on dose (Davies et al., 2021, Diabetes Care). Second, the starting dose matters. Dose escalation schedules exist specifically to reduce side effects, and skipping them is a common mistake. Third, combining semaglutide with metformin is generally well-tolerated, but hypoglycemia risk increases if other diabetes medications like sulfonylureas are also in the mix. Fourth, compounded semaglutide is not equivalent to brand-name Ozempic. If you are being offered a compounded version, that is a different product with different regulatory oversight.

• Ozempic is semaglutide, not "Zampic."
• The pre-filled pen contains multiple doses. Needles are replaced each use.
• Unopened pens go in the fridge. In-use pens are stable at room temperature for up to 56 days.
• High HbA1c plus metformin is a legitimate indication for adding semaglutide.
• GI side effects are real and common. Ask your prescriber about the titration schedule before starting.